Details for New Drug Application (NDA): 214031
✉ Email this page to a colleague
NDA 214031 describes VARDENAFIL HYDROCHLORIDE, which is a drug marketed by Alembic, Macleods Pharms Ltd, Crossmedika Sa, Stevens J, Teva Pharms, and Zydus Pharms, and is included in eight NDAs. It is available from eleven suppliers. Additional details are available on the VARDENAFIL HYDROCHLORIDE profile page.
The generic ingredient in VARDENAFIL HYDROCHLORIDE is vardenafil hydrochloride. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the vardenafil hydrochloride profile page.
The generic ingredient in VARDENAFIL HYDROCHLORIDE is vardenafil hydrochloride. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the vardenafil hydrochloride profile page.
Summary for 214031
| Tradename: | VARDENAFIL HYDROCHLORIDE |
| Applicant: | Alembic |
| Ingredient: | vardenafil hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 214031
| Mechanism of Action | Phosphodiesterase 5 Inhibitors |
Suppliers and Packaging for NDA: 214031
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| VARDENAFIL HYDROCHLORIDE | vardenafil hydrochloride | TABLET;ORAL | 214031 | ANDA | Alembic Pharmaceuticals Limited | 46708-236 | 46708-236-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-236-30) |
| VARDENAFIL HYDROCHLORIDE | vardenafil hydrochloride | TABLET;ORAL | 214031 | ANDA | Alembic Pharmaceuticals Limited | 46708-236 | 46708-236-31 | 100 TABLET, FILM COATED in 1 BOTTLE (46708-236-31) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 2.5MG BASE | ||||
| Approval Date: | Aug 4, 2020 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
| Approval Date: | Aug 4, 2020 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
| Approval Date: | Aug 4, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
